…CIHR COVID-19 Network of Clinical Trials Networks, co-principal investigator of the Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE/BALANCE+) Trials. He tries to devote a portion of each year…
Results for "covid"
Invitation to partner in the delivery and development of the ISARIC Clinical Characterisation Protocol
…on ~1,000,000 hospitalised COVID-19 patients and characterise the disease on a global scale. The benefits of prepositioned, agile, standardised and coordinated clinical research capability are now widely recognised. These include…
ISARIC launches Dengue Clinical Characterisation Protocol
…invited to collaborate and lead this science. In keeping with the collaborative approach of the CCP (including CCP-COVID-19), the CCP-Dengue tools and invitation to participate are open to all clinicians…
Case Report Forms
…ARChetype CRFs and the library of Templates ISARIC works closely with experts around the world to create CRFs for priority emerging and infectious diseases, such as mpox, Dengue, COVID and…
Clinical Characterisation Protocol
…(TYK2) that directly led to the development of a new, effective treatment for COVID-19: baricitinib. Beyond COVID-19, the CCP has supported research on various infectious diseases and outbreaks, including H5N1…
Member Assembly Agenda September 2024
Hosted by the Kumasi Centre for Collaborative Research in Tropical Medicine, Kwame Nkrumah University of Science and Technology Meeting objectives for attendees: Contribute to the next phase of ISARIC Learn…
Optimising Clinical Epidemiology in Disease Outbreaks: Analysis of ISARIC-WHO COVID-19 Case Report Form Utilisation
Towards rapid and secure sharing of epidemiological and clinical data to tackle emerging infectious diseases
…About the Partners ISARIC is a global, grass-roots consortium of over 60 clinical research networks in 140 countries, working together on epidemic infections such as COVID-19, pandemic influenza, Nipah virus,…
From silo to synergy: working together to accelerate defences against viral outbreaks – CEPI & ISARIC
…by the Wellcome Trust [Grant ref: 225767/Z/22/Z] through the COVID-19 Therapeutics Accelerator. Please contact the ISARIC Global Support Centre Communications Officer if you have any questions about this collaboration: wajeeha.malik@ndm.ox.ac.uk…
IMASOY
…control trial The impact of COVID-19 on clinical research for Neglected Tropical Diseases (NTDs): A case study of bubonic plague Rationale Current treatment regimens for bubonic plague rely heavily on…